+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glucosylceramidase Market - Global Forecast 2025-2030- Product Image
Glucosylceramidase Market - Global Forecast 2025-2030- Product Image
Sale

Glucosylceramidase Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013548
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Glucosylceramidase Market is at the forefront of diagnostic innovation, research breakthroughs, and therapeutic advancements, reflecting rapid evolution in enzyme analysis and clinical applications. This industry overview illustrates key market movements and emerging factors influencing strategic decisions for senior leadership across the biomedical value chain.

Market Snapshot: Glucosylceramidase Market Size and Growth Drivers

The Glucosylceramidase Market grew from USD 373.84 million in 2024 to USD 388.74 million in 2025 and is projected to reach USD 471.76 million by 2030 at a CAGR of 3.95%. This growth is powered by increasing demand for enzyme-based diagnostics, advances in structural biology, and expanding therapeutic pipelines targeting lysosomal storage disorders. Factors such as advances in enzyme sourcing, the adoption of new screening technologies, and collaborative ecosystems across regions continue to influence the pace of market expansion.

Scope & Segmentation: Analyzing Application, Source, Technology, and Regional Dynamics

This report provides a comprehensive breakdown of the Glucosylceramidase Market, with robust segmentation and regional coverage:

  • Application: Diagnostics (biomarker assays, imaging agents); Research (enzyme kinetics, structural analysis); Therapeutics (Fabry disease, Gaucher disease, Niemann-Pick disease)
  • Source: Animal, Microbial, Plant
  • Form: Liquid, Powder
  • End User: Diagnostics Laboratories, Pharmaceutical Companies, Research Institutes
  • Type: Natural, Recombinant
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Technologies Utilized: High-throughput screening, cryo-electron microscopy, nuclear magnetic resonance, artificial intelligence-driven enzyme kinetics, advanced imaging agent development, and automation platforms
  • Key Companies Profiled: Sanofi S.A., Takeda Pharmaceutical Company Limited, Pfizer Inc., Protalix BioTherapeutics, Inc., Merck KGaA

Key Takeaways: Strategic Insights for Decision-Makers

  • The evolving role of glucosylceramidase in biomedical innovation is fostering multi-layered collaborations between diagnostics laboratories, research institutes, and pharmaceutical manufacturers, driving efficiency and shared expertise.
  • Shifts from animal-derived to microbial and plant-based enzyme production are mitigating immunogenic risks while improving scalability and supply reliability.
  • Artificial intelligence and digital automation are accelerating discovery cycles, enhancing productivity in enzyme kinetics studies and screening processes.
  • Regional diversity in infrastructure, regulatory frameworks, and research capabilities encourages a localized approach to strategy and market entry.
  • Leading companies are aligning pipeline development with the latest regulatory requirements by forming strategic alliances and integrating advanced data management for robust quality control.

Tariff Impact: Navigating 2025 Trade Policy Shifts

The introduction of new tariffs in the United States for 2025 has altered the sourcing landscape for glucosylceramidase inputs. With additional duties now affecting imported raw materials—including those from animal, microbial, and plant origins—stakeholders are pivoting procurement strategies. Solutions being adopted include developing local partnerships, pursuing licensed technology transfers, and establishing co-development agreements to shield operations from rising costs and possible disruptions. These adjustments are integral to ensuring sustained access to high-quality enzyme formulations for diagnostics and therapeutics while managing price pressures.

Methodology & Data Sources: Ensuring Analytical Rigor

Our research utilizes a comprehensive blend of primary and secondary methods. Primary data is collected via structured interviews with key stakeholders, including enzymology specialists, clinical researchers, and supply chain managers. Secondary research involves systematic reviews of peer-reviewed literature, patent records, regulatory filings, and proprietary data sets. All inputs are validated using cross-verification checks, ensuring robust findings that reflect current market dynamics and regulatory environments.

Why This Report Matters: Value for Strategic Decision-Making

  • Delivers actionable insights to optimize sourcing strategies and mitigate regulatory or trade risks affecting glucosylceramidase supply chains.
  • Clarifies the competitive landscape, technology trends, and strategic partnerships shaping market trajectories for diagnostics and therapeutics.
  • Enables leaders to benchmark regional opportunities, leveraging local capabilities for improved market entry, technology adoption, and long-term growth.

Conclusion

Sustained growth in the Glucosylceramidase Market is shaped by ongoing advancements in science, production, and partnerships across the globe. Organizations that prioritize technological agility and regional alignment are well positioned to capture emerging opportunities in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of oral substrate reduction therapies as adjunct treatment for Gaucher disease across Asia Pacific markets
5.2. Increasing investment in gene therapy platforms targeting glucosylceramidase gene correction for rare lysosomal disorders
5.3. Growing focus on innovative enzyme encapsulation technologies to improve glucosylceramidase bioavailability and reduce infusion frequency
5.4. Impact of key biosimilar glucocerebrosidase entrants on pricing dynamics and reimbursement policies in Europe
5.5. Strategic partnerships between biotech startups and big pharma to accelerate glucosylceramidase pipeline diversification and scalability
5.6. Regulatory approval trends for next generation glucosylceramidase formulations with enhanced blood brain barrier penetration
5.7. Shifts in payer landscape driving value based pricing models for long term glucosylceramidase treatments in North America
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glucosylceramidase Market, by Application
8.1. Introduction
8.2. Diagnostics
8.2.1. Biomarker Assays
8.2.2. Imaging Agents
8.3. Research
8.3.1. Enzyme Kinetics
8.3.2. Structural Analysis
8.4. Therapeutics
8.4.1. Fabry Disease
8.4.2. Gaucher Disease
8.4.3. Niemann-Pick Disease
9. Glucosylceramidase Market, by Source
9.1. Introduction
9.2. Animal
9.3. Microbial
9.4. Plant
10. Glucosylceramidase Market, by Form
10.1. Introduction
10.2. Liquid
10.3. Powder
11. Glucosylceramidase Market, by End User
11.1. Introduction
11.2. Diagnostics Laboratories
11.3. Pharmaceutical Companies
11.4. Research Institutes
12. Glucosylceramidase Market, by Type
12.1. Introduction
12.2. Natural
12.3. Recombinant
13. Americas Glucosylceramidase Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Glucosylceramidase Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Glucosylceramidase Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Sanofi S.A.
16.3.2. Takeda Pharmaceutical Company Limited
16.3.3. Pfizer Inc.
16.3.4. Protalix BioTherapeutics, Inc.
16.3.5. Merck KGaA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GLUCOSYLCERAMIDASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLUCOSYLCERAMIDASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GLUCOSYLCERAMIDASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GLUCOSYLCERAMIDASE MARKET: RESEARCHAI
FIGURE 26. GLUCOSYLCERAMIDASE MARKET: RESEARCHSTATISTICS
FIGURE 27. GLUCOSYLCERAMIDASE MARKET: RESEARCHCONTACTS
FIGURE 28. GLUCOSYLCERAMIDASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GLUCOSYLCERAMIDASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY BIOMARKER ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY ENZYME KINETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY ENZYME KINETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY STRUCTURAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY STRUCTURAL ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY FABRY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY FABRY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY GAUCHER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY GAUCHER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY NIEMANN-PICK DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY NIEMANN-PICK DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY ANIMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY MICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY PLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY PLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GLUCOSYLCERAMIDASE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES GLUCOSYLCERAMIDASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 104. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 105. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 106. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 107. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 108. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 109. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 110. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 111. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 112. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 113. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 116. CANADA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 122. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 123. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 128. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 129. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 204. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 205. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 210. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 211. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. GERMANY GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 220. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 221. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 226. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 227. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 230. FRANCE GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 250. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 251. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 252. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 253. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 254. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 255. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 256. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 257. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 258. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 259. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 262. ITALY GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 263. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 266. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 267. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 268. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 269. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 274. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 275. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 278. SPAIN GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 330. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 331. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 332. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 333. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 334. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 335. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 336. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 337. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 338. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 339. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 342. DENMARK GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 353. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 354. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 355. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 356. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 357. NETHERLANDS GLUCOSYLCERAMIDASE MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 358. NETHERLANDS GLUCOSYLCERAMIDASE M

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Glucosylceramidase market report include:
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Protalix BioTherapeutics, Inc.
  • Merck KGaA

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 388.74 Million
Forecasted Market Value ( USD ) by 2030 $ 471.76 Million
Compound Annual Growth Rate3.9%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Healthcare Specialty Enzymes Market - Global Forecast 2025-2030 - Product Image

Healthcare Specialty Enzymes Market - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Heparinase Enzymes Market - Global Forecast 2025-2030 - Product Image

Heparinase Enzymes Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Proteinase K Market Size, Share & Trends Analysis Report By Form, By Therapeutic Area, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Proteinase K Market Size, Share & Trends Analysis Report By Form, By Therapeutic Area, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Imiglucerase), By Therapeutic Condition (MPS), By Route Of Administration (Oral), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Enzyme Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Imiglucerase), By Therapeutic Condition (MPS), By Route Of Administration (Oral), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Phospholipase Enzyme Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Phospholipase Enzyme Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 198 Pages
  • Global
From

About the Glucosylceramidase Market

Glucosylceramidase is an enzyme that catalyzes the hydrolysis of glucosylceramide, a type of glycolipid found in the cell membrane of many organisms. It is involved in the degradation of glycosphingolipids, which are important components of the cell membrane. Glucosylceramidase is used in the treatment of Gaucher's disease, a rare genetic disorder caused by the accumulation of glucosylceramide in the lysosomes of cells. It is also used in the diagnosis of other lysosomal storage diseases. The glucosylceramidase market is driven by the increasing prevalence of Gaucher's disease and other lysosomal storage diseases, as well as the growing demand for enzyme replacement therapy. The market is further supported by the increasing number of clinical trials and research activities related to glucosylceramidase. Some companies in the glucosylceramidase market include Sanofi, Pfizer, Shire, and Genzyme. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.